Empirical Therapy versus Diagnostic Tests in Gastroesophageal Reflux Disease (A Medical Decision Analysis)
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 43 (5) , 1001-1008
- https://doi.org/10.1023/a:1018874516807
Abstract
Our objective was to describe the conditionsthat determine the costs of empirical therapy ingastroesophageal reflux disease (GERD). Our design wasa threshold analysis using a decision tree. The costs...Keywords
This publication has 17 references indexed in Scilit:
- Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.1996
- Effective Maintenance Treatment of Reflux Esophagitis with Low-Dose LansoprazoleAnnals of Internal Medicine, 1996
- Prospective screening of dyspeptic patients by Helicobacter pylori serologyThe Lancet, 1995
- Prevalence of metaplasia at the gastro-oesophageal junctionThe Lancet, 1994
- Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.Gut, 1994
- Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitisGastroenterology, 1994
- OmeprazolePharmacoEconomics, 1993
- Screening dyspepsia by serology to Helicobacter pylori.1991
- Prevalence of columnar-lined (Barrett's) esophagusGastroenterology, 1990
- The Threshold Approach to Clinical Decision MakingNew England Journal of Medicine, 1980